The inhibition of NF-κβ activation reduced the expression of CXCR-4 (a receptor used for breast cancer cell migration) and reduced metastasis in BC cells by preventing epithelial–mesenchymal transition (EMT) [91]. The gene discussed is CXCR4; the disease is breast cancer.